Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
17 hedge funds and large institutions have $1.07M invested in Vaccinex, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 6 closing their positions.
6% less funds holding
Funds holding: 18 → 17 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
20.16% less ownership
Funds ownership: 53.17% → 33.01% (-20%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
95% less capital inflows, than outflows
Capital inflows: $56.1K | Capital outflows: $1.08M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$27.1K |
| 2 |
Two Sigma Investments
New York
|
+$13.6K |
| 3 |
XTX Topco
George Town,
Cayman Islands
|
+$9.91K |
| 4 |
Tower Research Capital (TRC)
New York
|
+$5.17K |
| 5 |
FCG
Financial Connections Group
Corte Madera,
California
|
+$225 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
-$768K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$231K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$53.6K |
| 4 |
Millennium Management
New York
|
-$15.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10.4K |
VCNX Hedge Fund Activity: Q4 2023 in Review
17 of the 6,873 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q4 2023, worth a combined $1.07M — down 63% from $2.92M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VCNX and 5 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $27.1K. The largest seller was Armistice Capital, exiting entirely with an estimated $768K sold.
- 17 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q4 2023, down from 18 in Q3 2023.
- Funds reported $1.07M of Vaccinex, Inc. Common Stock stock for Q4 2023, down 63% quarter-over-quarter.
- 5 funds opened new Vaccinex, Inc. Common Stock positions in Q4 2023 and 6 closed out, a net change of -1 holder.
- The largest Vaccinex, Inc. Common Stock buyer in Q4 2023 was Renaissance Technologies, an estimated $27.1K added.
- The largest Vaccinex, Inc. Common Stock seller in Q4 2023 was Armistice Capital, an estimated $768K sold.
Based on aggregated 13F filings for Q4 2023.